Morning Breakouts

Latest California Healthline Stories

Bush Advisor’s Meeting with PhRMA Sparks Conflict of Interest Talk

A June 5 “lobbying visit” by Pharmaceutical Research and Manufacturers of America president Alan Holmer with Karl Rove, President Bush’s top political strategist, “has raised some eyebrows on Capitol Hill” because at the time, Rove owned stock in two large drug companies, the National Journal reports.

Stanford to Transfer Graduate Students with Dependents from HMO to More Expensive PPO

Facing a “financial crisis,” Stanford Hospital and Clinics has announced that it will cancel its “money-losing” HMO contracts, including one that covers dependents of Stanford graduate students, the San Jose Mercury News reports.

Bush to Maintain Presidential Advisory Council on HIV/AIDS

The Bush administration will maintain the Presidential Advisory Council on HIV/AIDS — a panel established under former President Clinton — combining the council with President Bush’s Cabinet-level AIDS task force to address the administration’s AIDS agenda, AP/Milwaukee Journal-Sentinel reports.

Budget Impasse Continues as Assembly Republicans Protest Abortion Coverage Under Healthy Families Expansion

The impasse over the state budget for fiscal year 2001-02 continued yesterday, with Assembly Republicans “again closing ranks to block passage” of several appropriations measures needed to implement the spending plan, saying that a measure to expand Healthy Families would also expand funding for abortions, the Sacramento Bee reports.

NIH Report Questions Effectiveness of Condoms Against STDs

An NIH report to be released today says that there is “insufficient evidence” that male latex condoms prevent transmission of “most” STDs other than HIV and gonorrhea, giving advocates of “abstinence-only” sex education “fresh ammunition,” the Washington Post reports.

Johns Hopkins University Ordered to Halt Human Research

The federal Office of Human Research Protections yesterday ordered Johns Hopkins University to halt all federally funded human medical experiments after concluding that “widespread lapses in safety procedures” contributed to the June death of a 24-year-old woman who participated in an asthma study, the Baltimore Sun reports.